Surgeon General Warning – Cannabis’ Status as Schedule 1 Substance is Blocking Research

Surgeon General Warning: Cannabis’ Status as Schedule 1 Substance is Blocking Research Cannabis remaining a Schedule 1 substance in the United States is only doing more harm than good, and even health authorities are acknowledging this fact. Jerome Adams, surgeon general of POTUS, recommended revisiting cannabis’s status in the US…

Continue reading

DEA Reschedules Some Forms of CBD to Schedule 5 (What the #$%@ Does That Mean??)

DEA Reschedules Some Forms of CBD to Schedule 5 (What the #$ %@ Does That Mean??) So the US Drug Enforcement Administration (DEA) just rescheduled cannabidiol (CBD) – it’s no longer listed as a Schedule 1 substance, a category reserved for some of the most harmful and addictive substances known…

Continue reading

Lawsuit challenging Sessions and DEA on marijuana’s Schedule I status dismissed by federal judge

Published: Feb 26, 2018, 6:43 pm • Updated: Feb 26, 2018, 6:58 pm By Alex Pasquariello, The Cannabist Staff A federal judge on Monday dismissed a lawsuit pitting a diverse cadre of cannabis advocates against Attorney General Jeff Sessions and the Drug Enforcement Administration. The complaint filed in the Southern…

Continue reading

Why Big Pharma Would Love Cannabis Being a Schedule 2 Drug

How to Magically give Cannabis Medical Value according to the Federal Government For decades now the Federal government has been very clear about cannabis – “It has a high potential for abuse and NO ACCEPTED MEDICAL VALUE”. Obviously, people have become aware that this statement is not just inherently inaccurate,…

Continue reading

DEA finalizing Schedule II status for synthetic THC drug Syndros

Published: Nov 21, 2017, 8:50 am • Updated: Nov 21, 2017, 8:51 am By Alicia Wallace, The Cannabist Staff The U.S. Drug Enforcement Administration this week will grant Schedule II status to a synthetic THC drug developed by a pharmaceutical firm beset with controversy. The DEA on Wednesday is expected…

Continue reading

NJ court orders state to review marijuana’s Schedule I status, given “abundant” medical benefits

Published: Nov 1, 2017, 7:54 am • Updated: Nov 1, 2017, 1:04 pm By The Associated Press TRENTON, N.J. — An appeals court has ruled that New Jersey must reconsider marijuana’s legal classification because of its health benefits. NJ.com reports an appellate court ruled on Tuesday the Division of Consumer…

Continue reading

Federal lawsuit against Sessions and DEA says marijuana’s Schedule I status unconstitutional

Published: Jul 25, 2017, 7:10 am • Updated: Jul 25, 2017, 8:31 am By Alex Pasquariello, The Cannabist Staff A diverse cadre of cannabis advocates filed a federal lawsuit Monday challenging the constitutionality of the Controlled Substances Act (CSA) as it pertains to marijuana. Attorney General Jeff Sessions and Drug…

Continue reading

American Legion calls on Trump to take cannabis off Schedule I to help vets

Published: May 22, 2017, 4:07 pm • Updated: May 22, 2017, 4:57 pm By Bruce Kennedy, The Cannabist Staff America’s largest veterans service organization has a message for President Donald Trump: Reschedule marijuana to permit research into its medical efficacy for treating vets suffering from traumatic brain injury and post-traumatic…

Continue reading

New federal bill would reschedule marijuana as Schedule III

Published: Apr 7, 2017, 5:42 pm • Updated: Apr 7, 2017, 6:02 pm By Alicia Wallace, The Cannabist Staff The latest marijuana-centric bill before Congress would place cannabis as a Schedule III substance, a classification shared by Tylenol with codeine, ketamine and dronabinol. Two Florida congressmen, Republican Rep. Matt Gaetz…

Continue reading